0001209191-14-059536.txt : 20140924 0001209191-14-059536.hdr.sgml : 20140924 20140924112047 ACCESSION NUMBER: 0001209191-14-059536 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140924 FILED AS OF DATE: 20140924 DATE AS OF CHANGE: 20140924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vitae Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001157602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 502 WEST OFFICE CENTER DR CITY: FORT WASHINGTON STATE: PA ZIP: 19034 BUSINESS PHONE: 215-461-2000 MAIL ADDRESS: STREET 1: 502 WEST OFFICE CENTER DR CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Vitae Pharmaceuticals Inc DATE OF NAME CHANGE: 20050118 FORMER COMPANY: FORMER CONFORMED NAME: CONCURRENT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VEF MANAGEMENT III LLC CENTRAL INDEX KEY: 0001239246 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36617 FILM NUMBER: 141117702 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 30 ROCKFELLER PLACA RM 5508 CITY: NEW YORK STATE: NY ZIP: 10112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK ENTREPRENEURS FUND III LP CENTRAL INDEX KEY: 0001141515 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36617 FILM NUMBER: 141117703 BUSINESS ADDRESS: STREET 1: C/O VENROCK ASSOCIATES ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 BUSINESS PHONE: 212-649-5600 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK ASSOCIATES CENTRAL INDEX KEY: 0000937889 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36617 FILM NUMBER: 141117704 BUSINESS ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 BUSINESS PHONE: 2126495600 MAIL ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK ASSOCIATES III LP CENTRAL INDEX KEY: 0001119517 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36617 FILM NUMBER: 141117705 BUSINESS ADDRESS: STREET 1: 30 ROCKEFELLER PLAZA STREET 2: RM 5508 CITY: NEW YORK STATE: NY ZIP: 10112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK MANAGEMENT III LLC CENTRAL INDEX KEY: 0001239247 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36617 FILM NUMBER: 141117706 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 30 ROCKFELLER PLACA RM 5508 CITY: NEW YORK STATE: NY ZIP: 10112 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-09-24 0 0001157602 Vitae Pharmaceuticals, Inc VTAE 0001239247 VENROCK MANAGEMENT III LLC C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 0 0 1 0 0001119517 VENROCK ASSOCIATES III LP C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 0 0 1 0 0000937889 VENROCK ASSOCIATES C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 0 0 1 0 0001141515 VENROCK ENTREPRENEURS FUND III LP C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 0 0 1 0 0001239246 VEF MANAGEMENT III LLC C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 0 0 1 0 Series A-2 Preferred Stock Common Stock 48333 I See Footnote Series A-2 Preferred Stock Common Stock 214820 I See Footnote Series A-2 Preferred Stock Common Stock 5367 I See Footnote Series B Preferred Stock Common Stock 227117 I See Footnote Series B Preferred Stock Common Stock 1009414 I See Footnote Series B Preferred Stock Common Stock 25233 I See Footnote Series C Preferred Stock Common Stock 9285 I See Footnote Series C Preferred Stock Common Stock 41270 I See Footnote Series C Preferred Stock Common Stock 1031 I See Footnote Each share of Series A-2 Preferred Stock will automatically convert on a 1:1.50638118 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date. The reportable securities are owned by Venrock Associates. The reportable securities are owned by Venrock Associates III, L.P. ("VA III"). Venrock Management III, LLC ("VM III") is the general partner of VA III. VM III disclaims beneficial ownership of these securities and this report shall not be deemed an admission that it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. The reportable securities are owned by Venrock Entrepreneurs Fund III, L.P. ("VEF III"). VEF Management III, LLC ("VEFM III") is the general partner of VEF III. VEFM III disclaims beneficial ownership of these securities and this report shall not be deemed an admission it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. Each share of Series B Preferred Stock and Series C Preferred Stock will automatically convert on a 1:1 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date. /s/ David L. Stepp, Authorized Signatory, Venrock Associates III, L.P. 2014-09-24 /s/ David L. Stepp, Authorized Signatory, Venrock Associates 2014-09-24 /s/ David L. Stepp, Authorized Signatory, Venrock Entrepreneurs Fund III, L.P. 2014-09-24 /s/ David L. Stepp, Authorized Signatory, Venrock Management III, LLC 2014-09-24 /s/ David L. Stepp, Authorized Signatory, VEF Management III, LLC 2014-09-24